Oncore(R) Receives caBIG(TM) Bronze Compatibility Certification (PRWeb via Yahoo! News)

More Semantic Technology News

PercipEnz Technologies, Inc. , creators of the most widely adopted clinical trials management software system among cancer clinical research centers, has received notice that their flagship product, Oncore, has been awarded the coveted caBIG(tm) Bronze Compatibility Certification.

More items about Semantic Technology similar to this News

Oncore(R) Receives caBIG(TM) Bronze Compatibility Certification (PRWeb via Yahoo! News) PercipEnz Technologies, Inc., creators of the most widely adopted clinical trials management software system among cancer clinical research centers, has received notice that their flagship product, Oncore, has been awarded the coveted caBIG Bronze C... Oncore(R) Receives caBIG(TM) Bronze Compatibility Certification (PRWeb) PercipEnz Technologies, Inc., creators of the most widely adopted clinical trials management software system among cancer clinical research centers, has received notice that their flagship product, Oncore, has been awarded the coveted caBIG(tm) Bron... Oncore(R) Receives caBIG(TM) Bronze Compatibility Certification (PRWeb) PercipEnz Technologies, Inc., creators of the most widely adopted clinical trials management software system among cancer clinical research centers, has received notice that their flagship product, Oncore, has been awarded the coveted caBIG Bronze C... Cholesterol Drug Not Effective In Study A clinical trial of a widely used cholesterol drug has raised questions both about the medicine’s effectiveness and about the behavior of the pharmaceutical companies that conducted the study, cardiologists said Monday. ... Medarex Announces Presentations at Annual Meeting of the American Society of Clinical Oncology (PR Newswire via Yahoo! Finance) Medarex, Inc. announced today that the following clinical and preclinical abstracts for ipilimumab in melanoma, prostate cancer and other cancers, as well as for anti-PD-1 and anti-CD70 antibody candidates for cancer treatment, are expected to be th... LILLY ONCOLOGY TO UNVEIL MORE THAN 50 STUDIES AT ASCO 2008 (Bernama via Yahoo! Malaysia News) ATTENTION EDITOR, GENERAL DESK INDIANAPOLIS, May 2/PRNewswire-AsiaNet/ -- ALIMTA Lung Cancer Study Highlighting Key Histology Findings To Be Included In May 15 ASCO Live, Online Presscast Eli Lilly and Company will unveil data from more than 50 studi... Medarex Announces Presentations at Annual Meeting of the American ... PRINCETON, NJ, April 29 /- Medarex, Inc. (Nasdaq: MEDX ) announced today that the following clinical and preclinical abstracts for ipilimumab in melanoma, prostate cancer and other cancers, as well as for anti-PD-1 and anti-CD70 ... Semantic Web research at HP Labs – overview HP Labs has been at the forefront of Semantic Web research since 2000, helping to create the standards, contributing key technology pieces, conducting basic research and building ...